Asthma is a chronic inflammatory disease of the airways characterized by symptoms such as wheezing, shortness of breath, chest tightness, and coughing. This study focuses on individuals with mild to moderate asthma eligible for pulmonary rehabilitation, aiming to improve respiratory function, exercise tolerance, and quality of life.". Asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 20-40 years Diagnosed with asthma Asthma patients eligible for pulmonary rehabilitation should have mild to moderate asthma with PEFR = 40%, oxygen saturation = 90%, and occasional use of accessory muscles Presence of respiratory symptoms such as wheezing, shortness of breath, or asthma Willingness to participate in the study Ability to perform and complete the 6-Minute Walk Test (6MWT)
Exclusion criteria
Exclusion criteria: Cognitive impairment Severe co-morbidities indicating greater illness morbidity than asthma alone Complications from any other pulmonary diseases in addition to asthma Locomotor system problems that interfere with the evaluation/intervention protocol Irregular use of medication prescribed by a physician Significant cardiovascular diseases, pregnancy, or lactation Inability to perform physical exercise or engage in rehabilitation activities Patients unable or unwilling to attend training sessions regularly
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Anxiety and Depression Levels:Evaluates psychological symptoms related to asthma. Timepoint: Baseline, post-intervention (8 weeks), and 3-month follow-up. Method of measurement: Hospital Anxiety and Depression Scale (HADS).;Quality of Life:Assesses the impact of asthma on daily life and well-being. Timepoint: Baseline, post-intervention (8 weeks), and 3-month follow-up. Method of measurement: Asthma Quality of Life Questionnaire (AQLQ).;Functional Capacity:Measures physical endurance and capacity to perform exercise. Timepoint: Baseline and post-intervention (8 weeks). Method of measurement: 6-Minute Walk Test (6MWT). | — |
Primary
| Measure | Time frame |
|---|---|
| Dyspnea Severity :Measures the intensity of breathlessness during activities. Timepoint: Baseline, post-intervention (8 weeks), and 3-month follow-up. Method of measurement: Modified Borg Dyspnea Scale. | — |
Countries
Pakistan
Contacts
Riphah international university of Lahore